The main purpose of this study is to determine whether the antidepressant response of
escitalopram 30mg/day or escitalopram 20mg/day + pindolol, a beta blocker, is different
(faster) compared to a standard dose of escitalopram 20mg/day.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Markus KOSEL
Collaborators:
H. Lundbeck A/S University Hospital, Basel, Switzerland University Hospital, Geneva University of Lausanne Hospitals